@draycakaya's weight loss claims need context
Quick answer
Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely. Most evidence-based interventions show 5-15% body weight reduction with some degree of regain over time.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
Dr. Ayça Kaya (@draycakaya) claims she helped a patient lose 57 kg over 2 years with no weight regain. She's promoting an upcoming TV interview about "permanent weight loss" and uses hashtags suggesting this involves diet and medical intervention.
The post lacks specifics about methods, timeline details, or patient characteristics. It's essentially a before-and-after testimonial dressed up as medical expertise.
Is 57 kg weight loss in 2 years realistic?
Yes, but it depends entirely on starting weight and methods used. For someone starting at 150+ kg, losing 57 kg represents a 38% body weight reduction, which falls within ranges seen in bariatric surgery studies.
The Longitudinal Assessment of Bariatric Surgery (LABS) consortium found average weight loss of 31.5% at 3 years post-surgery. Some GLP-1 receptor agonists show impressive results too. The STEP 1 trial (Wilding et al., NEJM, 2021) demonstrated 14.9% weight loss with 2.4mg semaglutide at 68 weeks.
Without knowing this patient's starting weight, intervention type, or medical history, we can't assess whether 57 kg loss is remarkable or expected.
What about the "no weight regain" claim?
This is where things get suspicious. Weight regain is extremely common regardless of intervention method. The claim of zero regain over 2 years is statistically improbable.
Long-term studies consistently show weight regain. Even with bariatric surgery, patients typically regain 15-25% of lost weight by 2-5 years post-procedure. The Look AHEAD trial showed that intensive lifestyle interventions led to 6% weight loss at 1 year, but only 2.5% at 8 years.
For pharmacotherapy, the STEP 1 extension data shows some regain when patients discontinue treatment. Perfect maintenance is rare, not typical.
Why are these testimonials problematic?
Single patient stories don't represent typical outcomes. This type of content violates evidence-based medicine principles by presenting exceptional cases as standard results.
The European Association for the Study of Obesity emphasizes that realistic weight loss expectations are 5-10% of body weight for most interventions. Promoting dramatic outliers without context misleads patients about probable outcomes.
Social media testimonials also can't account for confounding factors like concurrent medical treatments, genetic predisposition, or socioeconomic variables that influence weight management success.
What should you actually know about weight maintenance?
Successful long-term weight maintenance requires ongoing intervention, not a finite treatment period. The National Weight Control Registry tracks people who've maintained 30+ pound losses for over a year.
Their data shows successful maintainers typically weigh themselves daily, exercise 60-90 minutes per day, eat breakfast regularly, and limit TV watching. These behaviors must continue indefinitely.
For medical interventions, maintenance often requires continued treatment. Stopping GLP-1 agonists typically leads to weight regain. The realistic goal isn't perfection but minimizing regain through sustainable lifestyle changes and ongoing medical support when appropriate.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @draycakaya's weight loss claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@draycakaya's weight loss claims need context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely.
FormBlends verdict
Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely. Most evidence-based interventions show 5-15% body weight reduction with some degree of regain over time.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely. Most evidence-based interventions show 5-15% body weight reduction with some degree of regain over time.
- Large weight losses (50+ kg) are possible but typically require intensive medical interventions like surgery or high-dose medications
- Zero weight regain over 2 years is statistically improbable based on long-term outcome studies across all intervention types
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Large weight losses (50+ kg) are possible but typically require intensive medical interventions like surgery or high-dose medications
- Zero weight regain over 2 years is statistically improbable based on long-term outcome studies across all intervention types
- The STEP 1 trial showed 14.9% average weight loss with semaglutide, but individual results vary dramatically
- Successful weight maintenance typically requires permanent lifestyle changes and often continued medical treatment
- Single patient testimonials don't represent typical outcomes and can create unrealistic expectations
- Evidence-based weight loss expectations are 5-10% of body weight for most medical interventions
- Long-term weight maintenance success requires ongoing behavioral strategies like daily weighing and regular exercise
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Ayça Kaya · Instagram creator
68.3K views on this video
Tam 2 yıl önce Canım @snmyncr78 ‘imle -57 kg vermiştikkkk💪💪💪 Veee 2 yıldır hiç geri kilo almadıkkkk🥰💕💪🧿 Canım @fatmademirturgut ‘umun röportajı ileeee yarın TRT HABERDEYİZ💕💕💕 Bekleniyors
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Ayça Kaya, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.